Genome-wide Association Study to Predict Treatment Response for Chemotherapy in Esophageal Squamous Cell Carcinoma
N/A
18 Years
N/A
18 Years
N/A
Not Enrolling
Both
Esophageal Squamous Cell Carcinoma.
Both
Esophageal Squamous Cell Carcinoma.
Trial Information
Genome-wide Association Study to Predict Treatment Response for Chemotherapy in Esophageal Squamous Cell Carcinoma
Inclusion Criteria:
- Histological confirmed esophageal squamous cell carcinoma
- Patients treated with Taxane or 5-FU or platinum based chemotherapy.
- provision of a signed written informed consent.
Exclusion Criteria:
- patients not signed written informed consent.
- patient unacceptable for study in the judgement of the investigator.
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
Biomarkers predictive
Outcome Description:
Biomarkers predictive of clinical response to Taxane or 5-fluorouracil or platinum based chemotherapy.
Outcome Time Frame:
24months
Safety Issue:
No
Authority:
Korea: Food and Drug Administration
Study ID:
2011-05-076
NCT ID:
NCT01498757
Start Date:
January 2012
Completion Date:
Related Keywords:
- Esophageal Squamous Cell Carcinoma.
- Carcinoma
- Carcinoma, Squamous Cell
- Esophageal Diseases
Name | Location |
|---|
